Rank | Gene Set | Z-score |
---|---|---|
1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 6.75156414 |
2 | glutamate secretion (GO:0014047) | 5.97181463 |
3 | synaptic vesicle exocytosis (GO:0016079) | 5.63226187 |
4 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.40335798 |
5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.27719686 |
6 | L-amino acid import (GO:0043092) | 5.12963454 |
7 | axon ensheathment in central nervous system (GO:0032291) | 5.06057407 |
8 | central nervous system myelination (GO:0022010) | 5.06057407 |
9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.01308497 |
10 | regulation of synaptic vesicle transport (GO:1902803) | 4.77110128 |
11 | neurotransmitter secretion (GO:0007269) | 4.70023433 |
12 | L-phenylalanine catabolic process (GO:0006559) | 4.62000989 |
13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.62000989 |
14 | cerebellar granule cell differentiation (GO:0021707) | 4.59812505 |
15 | potassium ion homeostasis (GO:0055075) | 4.59431072 |
16 | alpha-linolenic acid metabolic process (GO:0036109) | 4.59415509 |
17 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.59378854 |
18 | amino acid import (GO:0043090) | 4.56707410 |
19 | neuronal action potential propagation (GO:0019227) | 4.53583300 |
20 | positive regulation of synapse maturation (GO:0090129) | 4.50173165 |
21 | postsynaptic membrane organization (GO:0001941) | 4.49472314 |
22 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.41118685 |
23 | L-phenylalanine metabolic process (GO:0006558) | 4.41118685 |
24 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.36911750 |
25 | vocalization behavior (GO:0071625) | 4.25619074 |
26 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.20936274 |
27 | cellular sodium ion homeostasis (GO:0006883) | 4.08345061 |
28 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.05455954 |
29 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.04583878 |
30 | aromatic amino acid family catabolic process (GO:0009074) | 4.00706568 |
31 | lysine metabolic process (GO:0006553) | 3.96040018 |
32 | lysine catabolic process (GO:0006554) | 3.96040018 |
33 | neurotransmitter uptake (GO:0001504) | 3.94983897 |
34 | glutamate metabolic process (GO:0006536) | 3.93568590 |
35 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.90787857 |
36 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.90384941 |
37 | kynurenine metabolic process (GO:0070189) | 3.89649539 |
38 | exploration behavior (GO:0035640) | 3.89428394 |
39 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.86900850 |
40 | neurotransmitter transport (GO:0006836) | 3.84867198 |
41 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.80338210 |
42 | bile acid biosynthetic process (GO:0006699) | 3.78242641 |
43 | cellular ketone body metabolic process (GO:0046950) | 3.75766715 |
44 | aspartate family amino acid catabolic process (GO:0009068) | 3.73329249 |
45 | regulation of synapse maturation (GO:0090128) | 3.69646760 |
46 | neuronal ion channel clustering (GO:0045161) | 3.68801544 |
47 | glyoxylate metabolic process (GO:0046487) | 3.68746935 |
48 | high-density lipoprotein particle remodeling (GO:0034375) | 3.67937076 |
49 | regulation of neurotransmitter levels (GO:0001505) | 3.65329390 |
50 | regulation of synapse structural plasticity (GO:0051823) | 3.64589174 |
51 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.60419169 |
52 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.59469521 |
53 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.58309055 |
54 | positive regulation of dendritic spine development (GO:0060999) | 3.57529448 |
55 | sulfur amino acid catabolic process (GO:0000098) | 3.57208148 |
56 | dicarboxylic acid catabolic process (GO:0043649) | 3.55913114 |
57 | indole-containing compound catabolic process (GO:0042436) | 3.54942882 |
58 | indolalkylamine catabolic process (GO:0046218) | 3.54942882 |
59 | tryptophan catabolic process (GO:0006569) | 3.54942882 |
60 | neuromuscular process controlling balance (GO:0050885) | 3.54653054 |
61 | regulation of cholesterol esterification (GO:0010872) | 3.51223592 |
62 | reverse cholesterol transport (GO:0043691) | 3.48983374 |
63 | 2-oxoglutarate metabolic process (GO:0006103) | 3.48847637 |
64 | neuron cell-cell adhesion (GO:0007158) | 3.48385988 |
65 | short-chain fatty acid metabolic process (GO:0046459) | 3.46506115 |
66 | cellular modified amino acid catabolic process (GO:0042219) | 3.43402631 |
67 | cysteine metabolic process (GO:0006534) | 3.42046591 |
68 | regulation of cell communication by electrical coupling (GO:0010649) | 3.41024678 |
69 | regulation of triglyceride catabolic process (GO:0010896) | 3.40925949 |
70 | low-density lipoprotein particle remodeling (GO:0034374) | 3.39236045 |
71 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.39029504 |
72 | regulation of ARF protein signal transduction (GO:0032012) | 3.38842908 |
73 | synaptic transmission, glutamatergic (GO:0035249) | 3.38232026 |
74 | alpha-amino acid catabolic process (GO:1901606) | 3.37614647 |
75 | plasma lipoprotein particle remodeling (GO:0034369) | 3.36636544 |
76 | protein-lipid complex remodeling (GO:0034368) | 3.36636544 |
77 | macromolecular complex remodeling (GO:0034367) | 3.36636544 |
78 | positive regulation of membrane potential (GO:0045838) | 3.35646481 |
79 | regulation of synaptic plasticity (GO:0048167) | 3.34353030 |
80 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.33054007 |
81 | acidic amino acid transport (GO:0015800) | 3.32509614 |
82 | urea cycle (GO:0000050) | 3.32010102 |
83 | urea metabolic process (GO:0019627) | 3.32010102 |
84 | amino-acid betaine metabolic process (GO:0006577) | 3.31447239 |
85 | regulation of neurotransmitter secretion (GO:0046928) | 3.31020595 |
86 | gamma-aminobutyric acid transport (GO:0015812) | 3.29109827 |
87 | tryptophan metabolic process (GO:0006568) | 3.27077237 |
88 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.26594482 |
89 | cellular amino acid catabolic process (GO:0009063) | 3.26182912 |
90 | dendritic spine morphogenesis (GO:0060997) | 3.25610921 |
91 | cell communication involved in cardiac conduction (GO:0086065) | 3.24301661 |
92 | ketone body metabolic process (GO:1902224) | 3.23673057 |
93 | auditory behavior (GO:0031223) | 3.23620476 |
94 | serine family amino acid catabolic process (GO:0009071) | 3.23318385 |
95 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.23315415 |
96 | protein localization to synapse (GO:0035418) | 3.22924068 |
97 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.22697035 |
98 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.20065319 |
99 | negative regulation of fibrinolysis (GO:0051918) | 3.19926826 |
100 | homocysteine metabolic process (GO:0050667) | 3.17373396 |
101 | bile acid metabolic process (GO:0008206) | 3.15522171 |
102 | regulation of neurotransmitter transport (GO:0051588) | 3.12750029 |
103 | membrane depolarization during action potential (GO:0086010) | 3.12383190 |
104 | regulation of protein activation cascade (GO:2000257) | 3.11027684 |
105 | complement activation, alternative pathway (GO:0006957) | 3.09335607 |
106 | synaptic vesicle endocytosis (GO:0048488) | 3.09091219 |
107 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.08513112 |
108 | ethanol oxidation (GO:0006069) | 3.05000149 |
109 | nitrogen cycle metabolic process (GO:0071941) | 3.04373903 |
110 | neuron-neuron synaptic transmission (GO:0007270) | 3.04297593 |
111 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.03617030 |
112 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.03359599 |
113 | glutamate receptor signaling pathway (GO:0007215) | 3.03298729 |
114 | coenzyme catabolic process (GO:0009109) | 3.02933738 |
115 | acetyl-CoA metabolic process (GO:0006084) | 3.02895411 |
116 | regulation of fibrinolysis (GO:0051917) | 3.02872411 |
117 | regulation of dendritic spine development (GO:0060998) | 3.01169485 |
118 | neuromuscular synaptic transmission (GO:0007274) | 3.00990135 |
119 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.00752238 |
120 | cell communication by electrical coupling (GO:0010644) | 2.99881143 |
121 | long-term memory (GO:0007616) | 2.99756700 |
122 | activation of protein kinase A activity (GO:0034199) | 2.99212657 |
123 | fatty acid transmembrane transport (GO:1902001) | 2.97320958 |
124 | phospholipid efflux (GO:0033700) | 2.96783772 |
125 | regulation of postsynaptic membrane potential (GO:0060078) | 2.96401430 |
126 | negative regulation of sterol transport (GO:0032372) | 2.95635175 |
127 | negative regulation of cholesterol transport (GO:0032375) | 2.95635175 |
128 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.95582129 |
129 | protein carboxylation (GO:0018214) | 2.95582129 |
130 | regulation of female receptivity (GO:0045924) | 2.95260587 |
131 | sodium ion export (GO:0071436) | 2.95229544 |
132 | C4-dicarboxylate transport (GO:0015740) | 2.94936758 |
133 | alanine transport (GO:0032328) | 2.93333262 |
134 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.93118628 |
135 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.92871900 |
136 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.92783523 |
137 | regulation of vesicle fusion (GO:0031338) | 2.92638542 |
138 | L-glutamate transport (GO:0015813) | 2.92259368 |
139 | presynaptic membrane organization (GO:0097090) | 2.91581655 |
140 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.90149671 |
141 | carnitine shuttle (GO:0006853) | 2.90119750 |
142 | regulation of complement activation (GO:0030449) | 2.90004138 |
143 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.89759873 |
144 | regulation of cholesterol homeostasis (GO:2000188) | 2.88860832 |
145 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.88271347 |
146 | fatty acid beta-oxidation (GO:0006635) | 2.87746061 |
147 | positive regulation of fatty acid oxidation (GO:0046321) | 2.87151570 |
148 | glutamine family amino acid catabolic process (GO:0009065) | 2.86833300 |
149 | detection of calcium ion (GO:0005513) | 2.86227809 |
150 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.85158257 |
151 | cellular potassium ion homeostasis (GO:0030007) | 2.84901125 |
152 | locomotory exploration behavior (GO:0035641) | 2.83996618 |
153 | presynaptic membrane assembly (GO:0097105) | 2.83931707 |
154 | linoleic acid metabolic process (GO:0043651) | 2.83901513 |
155 | carboxylic acid catabolic process (GO:0046395) | 2.83524775 |
156 | organic acid catabolic process (GO:0016054) | 2.83524775 |
157 | positive regulation of lipid catabolic process (GO:0050996) | 2.83243056 |
158 | monocarboxylic acid catabolic process (GO:0072329) | 2.82783449 |
159 | layer formation in cerebral cortex (GO:0021819) | 2.82222414 |
160 | acylglycerol homeostasis (GO:0055090) | 2.82213799 |
161 | triglyceride homeostasis (GO:0070328) | 2.82213799 |
162 | long-term synaptic potentiation (GO:0060291) | 2.82117925 |
163 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.81490925 |
164 | membrane depolarization (GO:0051899) | 2.81439090 |
165 | aromatic amino acid family metabolic process (GO:0009072) | 2.81030482 |
166 | phospholipid homeostasis (GO:0055091) | 2.79953512 |
167 | succinate metabolic process (GO:0006105) | 2.77042710 |
168 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.76288014 |
169 | regulation of synaptic transmission (GO:0050804) | 2.76209455 |
170 | regulation of bile acid biosynthetic process (GO:0070857) | 2.75161905 |
171 | carnitine metabolic process (GO:0009437) | 2.74692875 |
172 | synaptic vesicle maturation (GO:0016188) | 2.74624824 |
173 | proline transport (GO:0015824) | 2.74541705 |
174 | drug catabolic process (GO:0042737) | 2.74136362 |
175 | regulation of actin filament-based movement (GO:1903115) | 2.74107995 |
176 | lipid oxidation (GO:0034440) | 2.72805597 |
177 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.72692112 |
178 | positive regulation of neurotransmitter transport (GO:0051590) | 2.71736900 |
179 | positive regulation of dendrite development (GO:1900006) | 2.71503722 |
180 | plasma lipoprotein particle clearance (GO:0034381) | 2.71237021 |
181 | fatty acid oxidation (GO:0019395) | 2.70765391 |
182 | fatty acid catabolic process (GO:0009062) | 2.69582879 |
183 | glycogen catabolic process (GO:0005980) | 2.68680315 |
184 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.67662690 |
185 | potassium ion import (GO:0010107) | 2.67421317 |
186 | tyrosine metabolic process (GO:0006570) | 2.67293980 |
187 | cellular glucuronidation (GO:0052695) | 2.66877936 |
188 | arginine metabolic process (GO:0006525) | 2.66243998 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.08914002 |
2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.21419377 |
3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.53010375 |
4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.50450065 |
5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.45938887 |
6 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.08236441 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.06621414 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.56744324 |
9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.51957447 |
10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.13064047 |
11 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.96361244 |
12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.92574398 |
13 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.91936727 |
14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.82092366 |
15 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.81620548 |
16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.81082846 |
17 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.78423411 |
18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.78423411 |
19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.74213008 |
20 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.67306830 |
21 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.66803531 |
22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.64535825 |
23 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.63586042 |
24 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.62615348 |
25 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.62523363 |
26 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.57491935 |
27 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.55809073 |
28 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.54108829 |
29 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.49802448 |
30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.49156558 |
31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.46627849 |
32 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.45571348 |
33 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43874199 |
34 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.41986111 |
35 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.41904188 |
36 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.41063015 |
37 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.40484619 |
38 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.37180764 |
39 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.33588004 |
40 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.32964140 |
41 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.30295298 |
42 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.30291982 |
43 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.29030807 |
44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.26999570 |
45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25693323 |
46 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.25409867 |
47 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.25393752 |
48 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.23219906 |
49 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21399510 |
50 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.20138255 |
51 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.19196643 |
52 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.15588570 |
53 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.15406996 |
54 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13235393 |
55 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.11248537 |
56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10781306 |
57 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.10760639 |
58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.10676560 |
59 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.09552548 |
60 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.09208819 |
61 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.04023342 |
62 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.03786611 |
63 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.02808760 |
64 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.02298721 |
65 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.02189947 |
66 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.00300913 |
67 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.99780081 |
68 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98966748 |
69 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.98568351 |
70 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98025533 |
71 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.97575398 |
72 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.95405173 |
73 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.94483813 |
74 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.94002342 |
75 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93971995 |
76 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93343222 |
77 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.92382528 |
78 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.91676443 |
79 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.91157011 |
80 | AR_19668381_ChIP-Seq_PC3_Human | 0.90815345 |
81 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.90804740 |
82 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.90404482 |
83 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.90404482 |
84 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.89931042 |
85 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.89765858 |
86 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87750846 |
87 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87502019 |
88 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.86023976 |
89 | RXR_22108803_ChIP-Seq_LS180_Human | 0.85682829 |
90 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.84235932 |
91 | KDM2B_26808549_Chip-Seq_K562_Human | 0.84096033 |
92 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84071595 |
93 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.82777871 |
94 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.81734601 |
95 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.81723347 |
96 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.81446494 |
97 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81218126 |
98 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81137464 |
99 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.81096174 |
100 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.81062163 |
101 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.81062163 |
102 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.80603958 |
103 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.80282901 |
104 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80049875 |
105 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.79901242 |
106 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.79895292 |
107 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.78945333 |
108 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.78899307 |
109 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78867486 |
110 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.78634957 |
111 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.78560822 |
112 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.78232798 |
113 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.77900919 |
114 | AR_25329375_ChIP-Seq_VCAP_Human | 0.77540771 |
115 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.77217023 |
116 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.77211964 |
117 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.76915597 |
118 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.76085056 |
119 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76033395 |
120 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.75967922 |
121 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.75646529 |
122 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.75193657 |
123 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.74992631 |
124 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.73273060 |
125 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.72706480 |
126 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.72610028 |
127 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.72604855 |
128 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72116690 |
129 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.71139553 |
130 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.71036954 |
131 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.69598077 |
132 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.68617895 |
133 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.67732169 |
134 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.66898145 |
135 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.66547203 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 5.20495507 |
2 | MP0005360_urolithiasis | 4.54360268 |
3 | MP0005085_abnormal_gallbladder_physiolo | 4.12910932 |
4 | MP0005365_abnormal_bile_salt | 3.89525149 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.20694351 |
6 | MP0004859_abnormal_synaptic_plasticity | 3.12722329 |
7 | MP0003646_muscle_fatigue | 2.64971769 |
8 | MP0010329_abnormal_lipoprotein_level | 2.64645272 |
9 | MP0002837_dystrophic_cardiac_calcinosis | 2.61861371 |
10 | MP0003806_abnormal_nucleotide_metabolis | 2.40308090 |
11 | MP0009840_abnormal_foam_cell | 2.38488800 |
12 | MP0003879_abnormal_hair_cell | 2.36995700 |
13 | MP0003252_abnormal_bile_duct | 2.34556714 |
14 | MP0002822_catalepsy | 2.30367592 |
15 | MP0000751_myopathy | 2.24501434 |
16 | MP0005332_abnormal_amino_acid | 2.19505187 |
17 | MP0004130_abnormal_muscle_cell | 2.10481637 |
18 | MP0005083_abnormal_biliary_tract | 2.04774442 |
19 | MP0000920_abnormal_myelination | 2.03254644 |
20 | MP0003329_amyloid_beta_deposits | 1.94041187 |
21 | MP0003635_abnormal_synaptic_transmissio | 1.92914096 |
22 | MP0003690_abnormal_glial_cell | 1.85074211 |
23 | MP0001970_abnormal_pain_threshold | 1.80983957 |
24 | MP0002735_abnormal_chemical_nociception | 1.76651670 |
25 | MP0004215_abnormal_myocardial_fiber | 1.73152600 |
26 | MP0003195_calcinosis | 1.71720493 |
27 | MP0002118_abnormal_lipid_homeostasis | 1.69260851 |
28 | MP0009745_abnormal_behavioral_response | 1.65184541 |
29 | MP0004270_analgesia | 1.63196584 |
30 | MP0004036_abnormal_muscle_relaxation | 1.56733615 |
31 | MP0002064_seizures | 1.56596379 |
32 | MP0009046_muscle_twitch | 1.54049684 |
33 | MP0002063_abnormal_learning/memory/cond | 1.47785055 |
34 | MP0000749_muscle_degeneration | 1.45581304 |
35 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.43752406 |
36 | MP0002066_abnormal_motor_capabilities/c | 1.42610447 |
37 | MP0004858_abnormal_nervous_system | 1.41159937 |
38 | MP0002909_abnormal_adrenal_gland | 1.41138093 |
39 | MP0003880_abnormal_central_pattern | 1.40127681 |
40 | MP0001666_abnormal_nutrient_absorption | 1.39527212 |
41 | MP0001486_abnormal_startle_reflex | 1.37731964 |
42 | MP0002557_abnormal_social/conspecific_i | 1.36970037 |
43 | MP0004811_abnormal_neuron_physiology | 1.36523258 |
44 | MP0000604_amyloidosis | 1.35423120 |
45 | MP0005646_abnormal_pituitary_gland | 1.33377155 |
46 | MP0004145_abnormal_muscle_electrophysio | 1.32985759 |
47 | MP0009780_abnormal_chondrocyte_physiolo | 1.32845074 |
48 | MP0005330_cardiomyopathy | 1.31262517 |
49 | MP0004084_abnormal_cardiac_muscle | 1.30370781 |
50 | MP0003634_abnormal_glial_cell | 1.29949523 |
51 | MP0003137_abnormal_impulse_conducting | 1.26389461 |
52 | MP0003075_altered_response_to | 1.22290637 |
53 | MP0002572_abnormal_emotion/affect_behav | 1.21404079 |
54 | MP0008569_lethality_at_weaning | 1.21262252 |
55 | MP0002882_abnormal_neuron_morphology | 1.20727610 |
56 | MP0002272_abnormal_nervous_system | 1.20498882 |
57 | MP0002269_muscular_atrophy | 1.19802035 |
58 | MP0000747_muscle_weakness | 1.19607593 |
59 | MP0005423_abnormal_somatic_nervous | 1.19599790 |
60 | MP0000778_abnormal_nervous_system | 1.19136447 |
61 | MP0003191_abnormal_cellular_cholesterol | 1.18901518 |
62 | MP0005319_abnormal_enzyme/_coenzyme | 1.18882118 |
63 | MP0005535_abnormal_body_temperature | 1.17478282 |
64 | MP0000609_abnormal_liver_physiology | 1.17422021 |
65 | MP0003633_abnormal_nervous_system | 1.16560735 |
66 | MP0000955_abnormal_spinal_cord | 1.16549701 |
67 | MP0001177_atelectasis | 1.16169810 |
68 | MP0004087_abnormal_muscle_fiber | 1.15605222 |
69 | MP0005620_abnormal_muscle_contractility | 1.14602291 |
70 | MP0001905_abnormal_dopamine_level | 1.13872438 |
71 | MP0006036_abnormal_mitochondrial_physio | 1.12541168 |
72 | MP0005167_abnormal_blood-brain_barrier | 1.12148028 |
73 | MP0003632_abnormal_nervous_system | 1.11719575 |
74 | MP0004885_abnormal_endolymph | 1.10886328 |
75 | MP0001501_abnormal_sleep_pattern | 1.10407859 |
76 | MP0006276_abnormal_autonomic_nervous | 1.10255490 |
77 | MP0001968_abnormal_touch/_nociception | 1.08644072 |
78 | MP0001440_abnormal_grooming_behavior | 1.06777574 |
79 | MP0002972_abnormal_cardiac_muscle | 1.06640312 |
80 | MP0005670_abnormal_white_adipose | 1.05268592 |
81 | MP0004019_abnormal_vitamin_homeostasis | 1.03275314 |
82 | MP0002229_neurodegeneration | 1.02579732 |
83 | MP0002254_reproductive_system_inflammat | 1.01166145 |
84 | MP0004085_abnormal_heartbeat | 1.00926723 |
85 | MP0003868_abnormal_feces_composition | 1.00880376 |
86 | MP0001963_abnormal_hearing_physiology | 1.00096891 |
87 | MP0001485_abnormal_pinna_reflex | 0.99671351 |
88 | MP0003787_abnormal_imprinting | 0.98468169 |
89 | MP0004043_abnormal_pH_regulation | 0.97160423 |
90 | MP0008874_decreased_physiological_sensi | 0.96599329 |
91 | MP0002734_abnormal_mechanical_nocicepti | 0.93682574 |
92 | MP0003705_abnormal_hypodermis_morpholog | 0.92898664 |
93 | MP0002971_abnormal_brown_adipose | 0.91300599 |
94 | MP0004147_increased_porphyrin_level | 0.91244046 |
95 | MP0004742_abnormal_vestibular_system | 0.91194414 |
96 | MP0003631_nervous_system_phenotype | 0.89435445 |
97 | MP0004924_abnormal_behavior | 0.88247000 |
98 | MP0005386_behavior/neurological_phenoty | 0.88247000 |
99 | MP0002078_abnormal_glucose_homeostasis | 0.87905331 |
100 | MP0002638_abnormal_pupillary_reflex | 0.87437390 |
101 | MP0002067_abnormal_sensory_capabilities | 0.87062112 |
102 | MP0001502_abnormal_circadian_rhythm | 0.86875319 |
103 | MP0002152_abnormal_brain_morphology | 0.86649261 |
104 | MP0005166_decreased_susceptibility_to | 0.84476696 |
105 | MP0006138_congestive_heart_failure | 0.84456721 |
106 | MP0008775_abnormal_heart_ventricle | 0.84157367 |
107 | MP0003656_abnormal_erythrocyte_physiolo | 0.82701103 |
108 | MP0002090_abnormal_vision | 0.82545223 |
109 | MP0005666_abnormal_adipose_tissue | 0.82368305 |
110 | MP0005551_abnormal_eye_electrophysiolog | 0.82247852 |
111 | MP0002184_abnormal_innervation | 0.81481602 |
112 | MP0001544_abnormal_cardiovascular_syste | 0.81116738 |
113 | MP0005385_cardiovascular_system_phenoty | 0.81116738 |
114 | MP0003011_delayed_dark_adaptation | 0.80996368 |
115 | MP0004142_abnormal_muscle_tone | 0.80662291 |
116 | MP0002106_abnormal_muscle_physiology | 0.80505008 |
117 | MP0002733_abnormal_thermal_nociception | 0.79971772 |
118 | MP0002736_abnormal_nociception_after | 0.79728827 |
119 | MP0006035_abnormal_mitochondrial_morpho | 0.78610198 |
120 | MP0004484_altered_response_of | 0.78431406 |
121 | MP0008872_abnormal_physiological_respon | 0.78288512 |
122 | MP0001984_abnormal_olfaction | 0.77927237 |
123 | MP0001986_abnormal_taste_sensitivity | 0.77504359 |
124 | MP0000579_abnormal_nail_morphology | 0.77281469 |
125 | MP0008961_abnormal_basal_metabolism | 0.75664387 |
126 | MP0004510_myositis | 0.74033051 |
127 | MP0003123_paternal_imprinting | 0.71652125 |
128 | MP0002332_abnormal_exercise_endurance | 0.71633598 |
129 | MP0005647_abnormal_sex_gland | 0.70812644 |
130 | MP0000759_abnormal_skeletal_muscle | 0.70412188 |
131 | MP0005369_muscle_phenotype | 0.69508417 |
132 | MP0001346_abnormal_lacrimal_gland | 0.68147127 |
133 | MP0002069_abnormal_eating/drinking_beha | 0.65242202 |
134 | MP0001299_abnormal_eye_distance/ | 0.59099266 |
135 | MP0003122_maternal_imprinting | 0.58665432 |
136 | MP0000566_synostosis | 0.57783208 |
137 | MP0002249_abnormal_larynx_morphology | 0.54076575 |
138 | MP0000026_abnormal_inner_ear | 0.52839489 |
139 | MP0005409_darkened_coat_color | 0.52424271 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 4.76398018 |
2 | Diplopia (HP:0000651) | 4.61870874 |
3 | Abnormality of binocular vision (HP:0011514) | 4.61870874 |
4 | Xanthomatosis (HP:0000991) | 4.45821553 |
5 | Intrahepatic cholestasis (HP:0001406) | 4.41789694 |
6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.39324770 |
7 | Ankle clonus (HP:0011448) | 4.37796600 |
8 | Febrile seizures (HP:0002373) | 4.36465650 |
9 | Hyperlipoproteinemia (HP:0010980) | 4.32617412 |
10 | Atonic seizures (HP:0010819) | 4.13499985 |
11 | Exercise-induced myalgia (HP:0003738) | 4.01579560 |
12 | Hyperammonemia (HP:0001987) | 3.95761872 |
13 | Ketosis (HP:0001946) | 3.93246026 |
14 | Supranuclear gaze palsy (HP:0000605) | 3.86370267 |
15 | Epileptic encephalopathy (HP:0200134) | 3.83357232 |
16 | Muscle fiber inclusion bodies (HP:0100299) | 3.71579599 |
17 | Obstructive sleep apnea (HP:0002870) | 3.70557545 |
18 | Hypoalphalipoproteinemia (HP:0003233) | 3.63669435 |
19 | Hypobetalipoproteinemia (HP:0003563) | 3.63425006 |
20 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.62516325 |
21 | Hyperglycinemia (HP:0002154) | 3.62187245 |
22 | Prolonged partial thromboplastin time (HP:0003645) | 3.57848239 |
23 | Hyperglycinuria (HP:0003108) | 3.56895825 |
24 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.54589392 |
25 | Ketoacidosis (HP:0001993) | 3.53315953 |
26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.52791404 |
27 | Abnormality of glycine metabolism (HP:0010895) | 3.52791404 |
28 | Hypoglycemic coma (HP:0001325) | 3.52344134 |
29 | Nemaline bodies (HP:0003798) | 3.49647120 |
30 | Hypolipoproteinemia (HP:0010981) | 3.40442939 |
31 | Myoglobinuria (HP:0002913) | 3.36613474 |
32 | Complement deficiency (HP:0004431) | 3.29170866 |
33 | Abnormal eating behavior (HP:0100738) | 3.27299878 |
34 | Myokymia (HP:0002411) | 3.25770261 |
35 | Muscle fiber splitting (HP:0003555) | 3.22311475 |
36 | Spastic gait (HP:0002064) | 3.16727210 |
37 | Exercise-induced muscle cramps (HP:0003710) | 3.13945544 |
38 | Cerebral inclusion bodies (HP:0100314) | 3.11780996 |
39 | Absence seizures (HP:0002121) | 3.09218634 |
40 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.03937955 |
41 | Focal motor seizures (HP:0011153) | 3.01093333 |
42 | Epidermoid cyst (HP:0200040) | 2.99409754 |
43 | Sudden death (HP:0001699) | 2.97174227 |
44 | Peripheral hypomyelination (HP:0007182) | 2.91106403 |
45 | Dysmetria (HP:0001310) | 2.89014284 |
46 | Progressive cerebellar ataxia (HP:0002073) | 2.87336331 |
47 | Truncal ataxia (HP:0002078) | 2.85128318 |
48 | Cerebral hypomyelination (HP:0006808) | 2.84313657 |
49 | Dialeptic seizures (HP:0011146) | 2.81167054 |
50 | Status epilepticus (HP:0002133) | 2.79496904 |
51 | Papilledema (HP:0001085) | 2.79109285 |
52 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.76885984 |
53 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.76767832 |
54 | Type 1 muscle fiber predominance (HP:0003803) | 2.76604166 |
55 | Annular pancreas (HP:0001734) | 2.74545174 |
56 | EMG: myopathic abnormalities (HP:0003458) | 2.73934570 |
57 | Mutism (HP:0002300) | 2.71754268 |
58 | Increased circulating renin level (HP:0000848) | 2.69733710 |
59 | Delayed CNS myelination (HP:0002188) | 2.65938337 |
60 | Hemiparesis (HP:0001269) | 2.65260361 |
61 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.58634033 |
62 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.58618026 |
63 | Atrioventricular block (HP:0001678) | 2.56849217 |
64 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.56590215 |
65 | Limb dystonia (HP:0002451) | 2.54912368 |
66 | Bundle branch block (HP:0011710) | 2.54500259 |
67 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.54267145 |
68 | Abnormality of methionine metabolism (HP:0010901) | 2.54027349 |
69 | Akinesia (HP:0002304) | 2.52376970 |
70 | Urinary urgency (HP:0000012) | 2.50855042 |
71 | Heart block (HP:0012722) | 2.50186632 |
72 | Calf muscle hypertrophy (HP:0008981) | 2.50020964 |
73 | Cholelithiasis (HP:0001081) | 2.47541535 |
74 | Gout (HP:0001997) | 2.45585250 |
75 | Poor eye contact (HP:0000817) | 2.44644755 |
76 | Foot dorsiflexor weakness (HP:0009027) | 2.44039509 |
77 | Action tremor (HP:0002345) | 2.43348239 |
78 | Rigidity (HP:0002063) | 2.42752873 |
79 | Hypercholesterolemia (HP:0003124) | 2.42364126 |
80 | Lower limb muscle weakness (HP:0007340) | 2.42071636 |
81 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.38717689 |
82 | Abnormal gallbladder morphology (HP:0012437) | 2.38293663 |
83 | Fetal akinesia sequence (HP:0001989) | 2.37933204 |
84 | Abnormality of the foot musculature (HP:0001436) | 2.37551533 |
85 | Myopathic facies (HP:0002058) | 2.37248406 |
86 | Sleep apnea (HP:0010535) | 2.37137311 |
87 | Scanning speech (HP:0002168) | 2.35082065 |
88 | Abnormality of the common coagulation pathway (HP:0010990) | 2.34296306 |
89 | Clonus (HP:0002169) | 2.34186407 |
90 | Joint hemorrhage (HP:0005261) | 2.33155904 |
91 | Skin nodule (HP:0200036) | 2.32263092 |
92 | Rapidly progressive (HP:0003678) | 2.29259540 |
93 | Dicarboxylic aciduria (HP:0003215) | 2.28567988 |
94 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.28567988 |
95 | Metabolic acidosis (HP:0001942) | 2.28497499 |
96 | Delusions (HP:0000746) | 2.28328701 |
97 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.27253395 |
98 | Abnormal atrioventricular conduction (HP:0005150) | 2.26703810 |
99 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.26117139 |
100 | Neuronal loss in central nervous system (HP:0002529) | 2.25880436 |
101 | Abnormality of serum amino acid levels (HP:0003112) | 2.25583968 |
102 | Hyperbilirubinemia (HP:0002904) | 2.25187058 |
103 | Sensorimotor neuropathy (HP:0007141) | 2.24932773 |
104 | Ventricular fibrillation (HP:0001663) | 2.23986442 |
105 | Dysdiadochokinesis (HP:0002075) | 2.23430501 |
106 | Bradykinesia (HP:0002067) | 2.22475854 |
107 | Hyporeflexia of lower limbs (HP:0002600) | 2.20957458 |
108 | Neonatal onset (HP:0003623) | 2.20817701 |
109 | Frequent falls (HP:0002359) | 2.20732098 |
110 | Postural instability (HP:0002172) | 2.20614349 |
111 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.19918231 |
112 | Focal dystonia (HP:0004373) | 2.19445665 |
113 | Hypoglycemic seizures (HP:0002173) | 2.18191357 |
114 | EMG: neuropathic changes (HP:0003445) | 2.16827507 |
115 | Lower limb amyotrophy (HP:0007210) | 2.15606691 |
116 | Generalized tonic-clonic seizures (HP:0002069) | 2.13378221 |
117 | Syncope (HP:0001279) | 2.12812875 |
118 | Ventricular arrhythmia (HP:0004308) | 2.12787182 |
119 | Fat malabsorption (HP:0002630) | 2.12041706 |
120 | Neurofibrillary tangles (HP:0002185) | 2.11931300 |
121 | Dysmetric saccades (HP:0000641) | 2.11153357 |
122 | Focal seizures (HP:0007359) | 2.10952283 |
123 | Abnormality of complement system (HP:0005339) | 2.09843704 |
124 | Atrial fibrillation (HP:0005110) | 2.08691608 |
125 | Megalencephaly (HP:0001355) | 2.07456796 |
126 | Cholecystitis (HP:0001082) | 2.06802336 |
127 | Abnormal gallbladder physiology (HP:0012438) | 2.06802336 |
128 | Hemiplegia (HP:0002301) | 2.06579806 |
129 | Hyperventilation (HP:0002883) | 2.06292312 |
130 | Late onset (HP:0003584) | 2.06178367 |
131 | Pheochromocytoma (HP:0002666) | 2.05146731 |
132 | Craniofacial dystonia (HP:0012179) | 2.04674381 |
133 | Cerebral edema (HP:0002181) | 2.04372132 |
134 | Lethargy (HP:0001254) | 2.03644361 |
135 | Anxiety (HP:0000739) | 2.02933495 |
136 | Muscle stiffness (HP:0003552) | 2.02749273 |
137 | Visual hallucinations (HP:0002367) | 2.02385973 |
138 | Subaortic stenosis (HP:0001682) | 2.01613898 |
139 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.01613898 |
140 | Abnormality of the calf musculature (HP:0001430) | 2.01382094 |
141 | Aplasia involving bones of the extremities (HP:0009825) | 2.00592519 |
142 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.00592519 |
143 | Aplasia of the phalanges of the hand (HP:0009802) | 2.00592519 |
144 | Difficulty running (HP:0009046) | 1.99993213 |
145 | Tetraplegia (HP:0002445) | 1.98523860 |
146 | Split foot (HP:0001839) | 1.97202114 |
147 | Abnormality of the Achilles tendon (HP:0005109) | 1.97150339 |
148 | Spastic tetraparesis (HP:0001285) | 1.96926123 |
149 | Rhabdomyolysis (HP:0003201) | 1.96280835 |
150 | Abnormality of the corticospinal tract (HP:0002492) | 1.96201209 |
151 | Impaired social interactions (HP:0000735) | 1.95468748 |
152 | Abnormal social behavior (HP:0012433) | 1.95468748 |
153 | Primary atrial arrhythmia (HP:0001692) | 1.95156016 |
154 | Insomnia (HP:0100785) | 1.94745737 |
155 | Epileptiform EEG discharges (HP:0011182) | 1.94424202 |
156 | Prolonged QT interval (HP:0001657) | 1.93838243 |
157 | Asymmetric septal hypertrophy (HP:0001670) | 1.93608460 |
158 | Torticollis (HP:0000473) | 1.93511043 |
159 | Amyloidosis (HP:0011034) | 1.93161254 |
160 | Myotonia (HP:0002486) | 1.92816306 |
161 | Abnormality of the intrinsic pathway (HP:0010989) | 1.92533038 |
162 | Intention tremor (HP:0002080) | 1.87860230 |
163 | Depression (HP:0000716) | 1.86107295 |
164 | Conjugated hyperbilirubinemia (HP:0002908) | 1.83741775 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 3.51511167 |
2 | LMTK2 | 3.50027178 |
3 | PHKG1 | 3.30365026 |
4 | PHKG2 | 3.30365026 |
5 | BCKDK | 2.98138797 |
6 | TRIB3 | 2.76389918 |
7 | UHMK1 | 2.67942734 |
8 | PINK1 | 2.58076087 |
9 | NTRK3 | 2.33446205 |
10 | MAP2K4 | 2.32205370 |
11 | SIK1 | 2.28740896 |
12 | NTRK2 | 2.14164418 |
13 | PRKD3 | 2.09362400 |
14 | DAPK2 | 1.94940601 |
15 | MAP3K4 | 1.94499350 |
16 | MAP3K9 | 1.93614113 |
17 | OBSCN | 1.83955833 |
18 | STK38 | 1.59878312 |
19 | PDK4 | 1.59664870 |
20 | PDK3 | 1.59664870 |
21 | CAMKK1 | 1.58843830 |
22 | PKN2 | 1.57497716 |
23 | TTN | 1.56751265 |
24 | NEK1 | 1.53745574 |
25 | PAK6 | 1.53448254 |
26 | KSR2 | 1.52585560 |
27 | MINK1 | 1.45565290 |
28 | MAP3K7 | 1.42101131 |
29 | CASK | 1.35584524 |
30 | MAP2K7 | 1.29714317 |
31 | RIPK1 | 1.25632377 |
32 | MAPK13 | 1.22901411 |
33 | PKN1 | 1.20581721 |
34 | PLK2 | 1.19718920 |
35 | NTRK1 | 1.19304190 |
36 | MARK1 | 1.15637482 |
37 | NEK6 | 1.11475906 |
38 | MUSK | 1.10507557 |
39 | MARK2 | 1.09445414 |
40 | INSRR | 1.09343460 |
41 | DMPK | 1.07962747 |
42 | FGFR4 | 1.06631198 |
43 | PAK3 | 1.04001131 |
44 | MAPK12 | 1.01968492 |
45 | PRKCH | 1.00709098 |
46 | RIPK4 | 0.97281319 |
47 | PRKCG | 0.93966314 |
48 | CDK5 | 0.91850326 |
49 | TNIK | 0.90410256 |
50 | DAPK1 | 0.90360029 |
51 | CAMK2G | 0.90214154 |
52 | PDPK1 | 0.86306289 |
53 | RET | 0.85937223 |
54 | MAPK10 | 0.85912955 |
55 | CDK15 | 0.84563151 |
56 | DYRK1A | 0.83282148 |
57 | TYRO3 | 0.82468099 |
58 | CAMK1 | 0.80893322 |
59 | FGFR2 | 0.80657328 |
60 | CDK18 | 0.79284440 |
61 | MAP3K13 | 0.78003176 |
62 | CAMK2A | 0.77624030 |
63 | ROCK2 | 0.77365431 |
64 | PDK1 | 0.76569946 |
65 | CAMK4 | 0.76330460 |
66 | PRKAA1 | 0.76171241 |
67 | CDK11A | 0.76090153 |
68 | PIK3CA | 0.75255508 |
69 | PDK2 | 0.74887989 |
70 | ERN1 | 0.74851306 |
71 | PRKAA2 | 0.73228369 |
72 | CDK14 | 0.73118632 |
73 | CDK19 | 0.70239383 |
74 | TAOK1 | 0.70124162 |
75 | CAMK1G | 0.69623702 |
76 | PRKD1 | 0.69029866 |
77 | LATS2 | 0.67720617 |
78 | PRKACG | 0.66508894 |
79 | ALK | 0.65267758 |
80 | SIK2 | 0.63414225 |
81 | LIMK1 | 0.62886039 |
82 | PTK6 | 0.62884433 |
83 | * SGK223 | 0.62776833 |
84 | * SGK494 | 0.62776833 |
85 | ERBB4 | 0.62394604 |
86 | STK11 | 0.62126815 |
87 | GRK5 | 0.61849700 |
88 | CAMK2D | 0.61839268 |
89 | KSR1 | 0.60236704 |
90 | FES | 0.60160710 |
91 | CDC42BPA | 0.59776623 |
92 | MAPK11 | 0.59108081 |
93 | MAP3K2 | 0.59083521 |
94 | MAP3K1 | 0.58758925 |
95 | ROCK1 | 0.58477976 |
96 | PRPF4B | 0.57986420 |
97 | PDGFRA | 0.57370145 |
98 | PRKCZ | 0.57057626 |
99 | RPS6KA3 | 0.56462469 |
100 | MYLK | 0.55980614 |
101 | CAMKK2 | 0.55750951 |
102 | CAMK1D | 0.52920068 |
103 | DAPK3 | 0.51887969 |
104 | PIK3CG | 0.49997756 |
105 | JAK2 | 0.49276841 |
106 | WNK1 | 0.48930498 |
107 | MAPK4 | 0.48520301 |
108 | PRKG1 | 0.47393409 |
109 | ARAF | 0.46413068 |
110 | MAP2K6 | 0.45575628 |
111 | OXSR1 | 0.44094105 |
112 | MAPKAPK5 | 0.43805072 |
113 | MAP2K1 | 0.43651037 |
114 | PTK2B | 0.43074572 |
115 | PRKACA | 0.42842661 |
116 | * SGK1 | 0.41537236 |
117 | RAF1 | 0.40904017 |
118 | * SGK3 | 0.40896568 |
119 | MAP3K11 | 0.40570401 |
120 | TIE1 | 0.40215148 |
121 | PRKACB | 0.40169337 |
122 | PRKG2 | 0.39667336 |
123 | BMX | 0.39628619 |
124 | ERBB2 | 0.39408968 |
125 | ICK | 0.38996358 |
126 | FYN | 0.38864386 |
127 | TAOK2 | 0.38098677 |
128 | TNK2 | 0.37959835 |
129 | JAK1 | 0.37514289 |
130 | BRSK1 | 0.37514048 |
131 | CAMK2B | 0.37226560 |
132 | BRAF | 0.36417321 |
133 | MAPK7 | 0.36099004 |
134 | PRKCA | 0.35413705 |
135 | CCNB1 | 0.32918729 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 5.40890383 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.24529164 |
3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.10945151 |
4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.91197446 |
5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55996617 |
6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.44063984 |
7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.27106441 |
8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.24213619 |
9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.23904649 |
10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.22300679 |
11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.18465328 |
12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.12864089 |
13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.99637623 |
14 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.98160323 |
15 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.96362518 |
16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.92366848 |
17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.78978525 |
18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.69732531 |
19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.67189268 |
20 | Bile secretion_Homo sapiens_hsa04976 | 1.66821563 |
21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.56897218 |
22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.55959547 |
23 | Peroxisome_Homo sapiens_hsa04146 | 1.48658697 |
24 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.41378150 |
25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.36639788 |
26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.36276485 |
27 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32462287 |
28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.23309184 |
29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22650595 |
30 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.16649323 |
31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.16326462 |
32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.14969810 |
33 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.13800153 |
34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13656046 |
35 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.11451642 |
36 | Long-term depression_Homo sapiens_hsa04730 | 1.11382036 |
37 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.08742539 |
38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.08647778 |
39 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.05625211 |
40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.05150340 |
41 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.03941596 |
42 | GABAergic synapse_Homo sapiens_hsa04727 | 1.03708132 |
43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.99468885 |
44 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.98976506 |
45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96809094 |
46 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.95773974 |
47 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.93732518 |
48 | Nicotine addiction_Homo sapiens_hsa05033 | 0.93004964 |
49 | Glioma_Homo sapiens_hsa05214 | 0.92959465 |
50 | Histidine metabolism_Homo sapiens_hsa00340 | 0.92523700 |
51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.91432387 |
52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.89367489 |
53 | Gap junction_Homo sapiens_hsa04540 | 0.87687261 |
54 | Melanogenesis_Homo sapiens_hsa04916 | 0.87374493 |
55 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.87275843 |
56 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.85973253 |
57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.85385379 |
58 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.84346880 |
59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.84245538 |
60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.84221934 |
61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83015198 |
62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82441372 |
63 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.81673714 |
64 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.76292607 |
65 | Retinol metabolism_Homo sapiens_hsa00830 | 0.76003818 |
66 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.75965588 |
67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.75678555 |
68 | ABC transporters_Homo sapiens_hsa02010 | 0.74765040 |
69 | Circadian entrainment_Homo sapiens_hsa04713 | 0.72768236 |
70 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.71524601 |
71 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.70832421 |
72 | Insulin secretion_Homo sapiens_hsa04911 | 0.69362948 |
73 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68200522 |
74 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.68179594 |
75 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.67703395 |
76 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66848941 |
77 | Salivary secretion_Homo sapiens_hsa04970 | 0.65257252 |
78 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.64688464 |
79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64447636 |
80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63744645 |
81 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.63740617 |
82 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.63735012 |
83 | Olfactory transduction_Homo sapiens_hsa04740 | 0.63234810 |
84 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.63137767 |
85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61489309 |
86 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.61351433 |
87 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60381819 |
88 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.58854832 |
89 | Morphine addiction_Homo sapiens_hsa05032 | 0.58403557 |
90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58275764 |
91 | Mineral absorption_Homo sapiens_hsa04978 | 0.57058000 |
92 | Lysine degradation_Homo sapiens_hsa00310 | 0.56693887 |
93 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55914680 |
94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55705583 |
95 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.54891369 |
96 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.54146038 |
97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54038341 |
98 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.52739192 |
99 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.52633360 |
100 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51965871 |
101 | Insulin resistance_Homo sapiens_hsa04931 | 0.51086679 |
102 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.49800172 |
103 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.49606929 |
104 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49222705 |
105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48726351 |
106 | Long-term potentiation_Homo sapiens_hsa04720 | 0.48597664 |
107 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.46440282 |
108 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46116101 |
109 | Axon guidance_Homo sapiens_hsa04360 | 0.45259624 |
110 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.44204969 |
111 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43863190 |
112 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.43500204 |
113 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43418381 |
114 | Renin secretion_Homo sapiens_hsa04924 | 0.42159714 |
115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41637163 |
116 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41481618 |
117 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.39603383 |
118 | Endocytosis_Homo sapiens_hsa04144 | 0.39553502 |
119 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.38995643 |
120 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38876516 |
121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38295032 |
122 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36899781 |
123 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36848255 |
124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36758504 |
125 | Tight junction_Homo sapiens_hsa04530 | 0.36515069 |
126 | Sulfur relay system_Homo sapiens_hsa04122 | 0.36427478 |
127 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36382421 |
128 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.35921855 |
129 | Prion diseases_Homo sapiens_hsa05020 | 0.35633438 |
130 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.35021380 |
131 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.34840380 |
132 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.34589832 |
133 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.33874857 |
134 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.33224271 |
135 | Cocaine addiction_Homo sapiens_hsa05030 | 0.32705482 |
136 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.32686261 |
137 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32593838 |
138 | Circadian rhythm_Homo sapiens_hsa04710 | 0.31369834 |
139 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.31207760 |
140 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.30624694 |
141 | Taste transduction_Homo sapiens_hsa04742 | 0.30139259 |
142 | Phototransduction_Homo sapiens_hsa04744 | 0.28613070 |
143 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27263731 |
144 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.25674234 |